Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Jan;3(1):39-46.
doi: 10.3945/an.111.001271. Epub 2012 Jan 5.

Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms

Affiliations
Review

Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms

Abigail J Larson et al. Adv Nutr. 2012 Jan.

Abstract

Epidemiological studies beginning in the 1990s have reported that intake of quercetin, a polyphenolic flavonoid found in a wide variety of plant-based foods, such as apples, onions, berries, and red wine, is inversely related to cardiovascular disease. More recent work using hypertensive animals and humans (>140 mm Hg systolic and >90 mm Hg diastolic) indicates a decrease in blood pressure after quercetin supplementation. A number of proposed mechanisms may be responsible for the observed blood pressure decrease such as antioxidant effects, inhibition of angiotensin-converting enzyme activity, and improved endothelium-dependent and -independent function. The majority of these mechanisms have been identified using animal models treated with quercetin, and relatively few have been corroborated in human studies. The purpose of this review is to examine the evidence supporting the role of quercetin as a potential therapeutic agent and the mechanisms by which quercetin might exert its blood pressure-lowering effect.

PubMed Disclaimer

Conflict of interest statement

Author disclosures: A.J. Larson, J.D. Symons, and T. Jalili, no conflicts of interest.

Figures

Figure 1
Figure 1
Chemical structure of quercetin and its various forms.
Figure 2
Figure 2
Summary of blood pressure changes observed after a double-blind, placebo-controlled trial comparing 4 wk of 760 mg/d quercetin supplementation vs. placebo in male and female patients with hypertension. MAP, mean arterial pressure. Values are mean ± SE, n = 22 stage 1 hypertensive, n = 19 Prehypertensive. *Different from placebo; P < 0.05. Adapted with permission from (10).
Figure 3
Figure 3
Overview of possible mechanisms based on available in vitro and in vivo evidence by which quercetin (Q) may interact with the renin-angiotensin-aldosterone system to decrease blood pressure, as reviewed in the text.

Similar articles

Cited by

References

    1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, et al. Heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–215 Erratum in: Circulation. 2010;121:e260 - PubMed
    1. Sica DA. Angiotensin-converting enzyme inhibitor use in the year 2005. J Clin Hypertens (Greenwich). 2005;7:8–11 - PMC - PubMed
    1. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER, 3rd, Simons-Morton DG, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10 - PubMed
    1. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–24 - PubMed
    1. Padilla J, Wallace JP, Park S. Accumulation of physical activity reduces blood pressure in pre- and hypertension. Med Sci Sports Exerc. 2005;37:1264–75 - PubMed

Publication types

MeSH terms

-